30 January 2025
TREATT PLC (“Treatt” or “the Group”) AGM Trading Update Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and…
Fevertree Drinks plc (“Fever-Tree” or the “Company”) Fever-Tree announces a Strategic Partnership with Molson Coors to drive the next stage of growth in the…
29 January 2025
HARGREAVES SERVICES PLC (the “Group”, the “Company” or “Hargreaves”) Interim Results for the six months ended 30 November 2024 Hargreaves Services plc (AIM: HSP),…
28 January 2025
Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris / New York – 28 January 2025 – Euronext (Euronext: ENX), the leading European capital market infrastructure,…
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP GSK plc (LSE/NYSE: GSK) today announced…
HENRY BOOT PLC (‘Henry Boot’ or ‘the group’) TRADING UPDATE FOR THE YEAR ENDED 31 DECEMBER 2024 Henry Boot, a company engaged in land…
Harworth Group plc (“Harworth” or “the Group”) Trading Update Strong operational performance and record land sales driving NDV growth Harworth, a leading regenerator of…
Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more…